Investors seeking to outperform the market should focus their stock-picking efforts on volatile names in the consumer ...

Barclays downgraded shares of Moderna (NASDAQ:MRNA – Free Report) from an overweight rating to an equal weight rating in a report published on Tuesday, Ratings reports. The firm currently has $45.00 ...

EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...

In a report released on February 14, Luca Issi from RBC Capital maintained a Hold rating on Moderna (MRNA – Research Report), with a price ...

These three premier ASX healthcare stocks just reported half-yearly earnings – and each saw its share price dip…So, is now the time to buy?

Goldman Sachs has appointed insiders William Connolly and Michael Voris as co-heads of Equity Capital Markets (ECM) in the ...

Goldman Sachs analyst Matt Greene maintained a Buy rating on Glencore (GLEN – Research Report) today and set a price target of £5.00. The ...

He said that hedge fund ownership of potential deregulation beneficiaries, stocks with small business exposure, and domestic ...

Goldman Sachs raised its forecast to $3,100/oz from $2,890 on central bank buying and inflows into exchange-traded funds in a note Monday, while Morgan Stanley has a forecast of $2,700.

Learn More The gold price rose to a new record above US$2,940 per ounce last week, and top broker Goldman Sachs reckons this safe-haven asset has more room to run this year. The Australian ...

Strategists at Goldman Sachs Group Inc. expect a blistering rally in Chinese equities to continue, as the emergence of DeepSeek sparks optimism over the country’s technological advancements.